Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2025-12-25 @ 3:18 AM
NCT ID:
NCT00005605
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven stage I or II breast cancer
* Must be scheduled to receive adjuvant chemotherapy with or without tamoxifen
* Hormone receptor status:
* Not specified
PATIENT CHARACTERISTICS:
Age:
* 35 to 50
Sex:
* Female
Menopausal status:
* Premenopausal by follicle-stimulating hormone and estradiol levels
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* Not pregnant
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* See Disease Characteristics
Endocrine therapy:
* See Disease characteristics
Radiotherapy:
* Not specified
Surgery:
* Not specified
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
35 Years
Maximum Age:
50 Years
Study:
NCT00005605
Study Brief:
Protocol Section:
NCT00005605